ArticleLeukemia2017
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
M H Qazilbash et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this paperpooled ittrialcites it